Ming‐Hao Dong

Anti-BCMA CAR T-cell therapy CT103A in relapsed or refractory AQP4-IgG seropositive neuromyelitis optica spectrum disorders: phase 1 trial interim results

Chuan Qin, Dai‐Shi Tian, Luo‐Qi Zhou et al. · Signal Transduction and Targeted Therapy · 2023 · 158 citations · Full text

Life Sciences, Immunology, Neurology +16

Single-cell analysis of refractory anti-SRP necrotizing myopathy treated with anti-BCMA CAR-T cell therapy

Chuan Qin, Ming‐Hao Dong, Luo‐Qi Zhou et al. · Proceedings of the National Academy of Sciences · 2024 · 75 citations · Full text

Life Sciences, Immunology, Pharmacology +17

B cell lineage reconstitution underlies CAR-T cell therapeutic efficacy in patients with refractory myasthenia gravis

Dai‐Shi Tian, Chuan Qin, Ming‐Hao Dong et al. · EMBO Molecular Medicine · 2024 · 66 citations · Full text

Life Sciences, Immunology, Molecular Medicine +17

Single-cell analysis of anti-BCMA CAR T cell therapy in patients with central nervous system autoimmunity

Chuan Qin, Min Zhang, Dapeng Mou et al. · Science Immunology · 2024 · 55 citations · Full text

Life Sciences, Immunology, Neuroscience +17

Soluble TREM2 triggers microglial dysfunction in neuromyelitis optica spectrum disorders

Man Chen, Ming‐Hao Dong, Sheng Yang et al. · Brain · 2023 · 40 citations · Full text

Life Sciences, Neurology, Neuroscience +16